Rho-kinase inhibitors offer a new approach in the treatment of glaucoma

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.23, Iss.1, 2014-01, pp. : 81-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma

Current Drug Delivery, Vol. 13, Iss. 6, 2016-09 ,pp. : 818-829

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka Shimokawa Hiroaki

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Rho-kinase inhibitors show promise in pulmonary hypertension

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1157-1159

Informa Healthcare

Access to resources Recommend Favorite

Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 339-348

Bentham Science Publishers

Access to resources Recommend Favorite

Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction

Current Pharmaceutical Design, Vol. 11, Iss. 31, 2005-12 ,pp. : 4029-4040

Bentham Science Publishers

Access to resources Recommend Favorite